Position in FHTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$801,569
+$150,973 QoQ
Shares Held
164,256
+20.7% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 102 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. FHTX ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in FHTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $801,569 | 164,256 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $650,596 | 136,108 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $640,985 | 118,701 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $354,265 | 72,447 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $164,034 | 34,901 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $205,610 | 56,332 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $352,376 | 74,656 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $424,135 | 45,557 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $87,365 | 15,194 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $76,634 | 11,421 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $91,854 | 14,241 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $79,755 | 15,951 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $107,127 | 15,217 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $192,664 | 31,075 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $216,172 | 33,883 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $145,190 | 16,922 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $222,740 | 16,378 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $200,198 | 13,145 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $833,450 | 36,443 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $178,429 | 12,809 | Shares | Defined | 2022-01-20 | |
| 2020-12-31 | $219,828 | 10,845 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||